Wordt geladen...
Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy
Buruli ulcer (BU) vaccine design faces similar challenges to those observed during development of prophylactic tuberculosis treatments. Multiple BU vaccine candidates, based upon Mycobacterium bovis BCG, altered Mycobacterium ulcerans (MU) cells, recombinant MU DNA, or MU protein prime-boosts, have...
Bewaard in:
| Gepubliceerd in: | PLoS Negl Trop Dis |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5179062/ https://ncbi.nlm.nih.gov/pubmed/27941982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0005229 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|